Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated:  10/13/2015
Novartis Investigative Site
mi
from
Norfolk, VA
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated: 10/13/2015
Novartis Investigative Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated:  10/13/2015
Novartis Investigative Site
mi
from
Richmond, VA
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated: 10/13/2015
Novartis Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated:  10/13/2015
Novartis Investigative Site
mi
from
Seattle, WA
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated: 10/13/2015
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated:  10/13/2015
Novartis Investigative Site
mi
from
Spokane, WA
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated: 10/13/2015
Novartis Investigative Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated:  10/13/2015
Novartis Investigative Site
mi
from
Montreal,
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
A 12 Month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing Safety and Efficacy of Concentration-controlled Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in de Novo Renal Transplant Recipients
Status: Enrolling
Updated: 10/13/2015
Novartis Investigative Site
mi
from
Montreal,
Click here to add this to my saved trials
Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
Multicenter Trial Using Multi-dose Rituximab as Induction and Desensitization Therapy for Patients on the Waiting List for Kidney Transplant With a Positive Donor Specific Crossmatch to a Living Donor
Status: Enrolling
Updated:  10/13/2015
University of Wisconsin
mi
from
Madison, WI
Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
Multicenter Trial Using Multi-dose Rituximab as Induction and Desensitization Therapy for Patients on the Waiting List for Kidney Transplant With a Positive Donor Specific Crossmatch to a Living Donor
Status: Enrolling
Updated: 10/13/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant
Cytokine Kinetics Assay to Assess the Presence or Absence of Tolerance in Organ Transplant Recipients
Status: Enrolling
Updated:  10/13/2015
University of Wisconsin
mi
from
Madison, WI
Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant
Cytokine Kinetics Assay to Assess the Presence or Absence of Tolerance in Organ Transplant Recipients
Status: Enrolling
Updated: 10/13/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Outlook Quality of Life Intervention Study
Outlook: An Intervention to Improve Quality of Life in Serious Illness Study
Status: Enrolling
Updated:  10/19/2015
Durham VA Medical Center HSR&D COE
mi
from
Durham, NC
Outlook Quality of Life Intervention Study
Outlook: An Intervention to Improve Quality of Life in Serious Illness Study
Status: Enrolling
Updated: 10/19/2015
Durham VA Medical Center HSR&D COE
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Southwest Clinical Research Institute
mi
from
Tempe, AZ
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Southwest Clinical Research Institute
mi
from
Tempe, AZ
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Advanced Kidney Medical Group, Inc
mi
from
Bakersfield, CA
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Advanced Kidney Medical Group, Inc
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Kidney Wellness Center
mi
from
Long Beach, CA
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Kidney Wellness Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Ontario Dialysis Center
mi
from
Ontario, CA
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Ontario Dialysis Center
mi
from
Ontario, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Kidney Center, Inc.
mi
from
Simi Valley, CA
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Kidney Center, Inc.
mi
from
Simi Valley, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
American Institute of Research
mi
from
Whittier, CA
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
American Institute of Research
mi
from
Whittier, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Denver Nephrologist, PC
mi
from
Denver, CO
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Denver Nephrologist, PC
mi
from
Denver, CO
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
South Florida Research Institute
mi
from
Lauderdale Lakes, FL
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
South Florida Research Institute
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Northwest Louisiana Nephrology
mi
from
Shreveport, LA
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Northwest Louisiana Nephrology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
A. Kaldun Nossuli, MD -- Research
mi
from
Bethesda, MD
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
A. Kaldun Nossuli, MD -- Research
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Nephrology Associates, PC
mi
from
Nashville, TN
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Nephrology Associates, PC
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Arlington Nephrology
mi
from
Arlington, TX
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Arlington Nephrology
mi
from
Arlington, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Millennium Clinical Research, Inc
mi
from
Houston, TX
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Millennium Clinical Research, Inc
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Southwest Houston Research, Ltd
mi
from
Houston, TX
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Southwest Houston Research, Ltd
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
Kidney & Hypertension Specialists
mi
from
San Antonio, TX
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
Kidney & Hypertension Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
U.S. Renal Care
mi
from
San Antonio, TX
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
U.S. Renal Care
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
University of Wisconsin - Madison
mi
from
Fitchburg, WI
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
University of Wisconsin - Madison
mi
from
Fitchburg, WI
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/20/2015
NorthShore University HealthSystem
mi
from
Evanston, IL
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/20/2015
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated:  10/21/2015
North Shore-LIJ Health System/Center for Advanced Medicine - North Shore University Hospital
mi
from
Lake Success, NY
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated: 10/21/2015
North Shore-LIJ Health System/Center for Advanced Medicine - North Shore University Hospital
mi
from
Lake Success, NY
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated:  10/21/2015
Gabrail Cancer Center
mi
from
Canton, OH
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated: 10/21/2015
Gabrail Cancer Center
mi
from
Canton, OH
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated:  10/21/2015
Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic
mi
from
Nashville, TN
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated: 10/21/2015
Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated:  10/21/2015
Baylor Charles A Sammons Cancer Center
mi
from
Dallas, TX
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated: 10/21/2015
Baylor Charles A Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated:  10/21/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated: 10/21/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated:  10/21/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated: 10/21/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated:  10/21/2015
Royal Prince Alfred Hospital
mi
from
Camperdown,
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease
Status: Enrolling
Updated: 10/21/2015
Royal Prince Alfred Hospital
mi
from
Camperdown,
Click here to add this to my saved trials
IVC Collapsibility Index in Patients With Acute Kidney Injury
IVC Collapsibility Index in Patients With Acute Kidney Injury
Status: Enrolling
Updated:  10/21/2015
Texas Tech Univrsity Health Science center
mi
from
Lubbock, TX
IVC Collapsibility Index in Patients With Acute Kidney Injury
IVC Collapsibility Index in Patients With Acute Kidney Injury
Status: Enrolling
Updated: 10/21/2015
Texas Tech Univrsity Health Science center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated:  10/23/2015
Columbia University Medical Center
mi
from
New York, NY
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated: 10/23/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated:  10/23/2015
Stanford University
mi
from
San Francisco, CA
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated: 10/23/2015
Stanford University
mi
from
San Francisco, CA
Click here to add this to my saved trials
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated:  10/23/2015
The University of Ohio
mi
from
Columbus, OH
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated: 10/23/2015
The University of Ohio
mi
from
Columbus, OH
Click here to add this to my saved trials
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated:  10/23/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated: 10/23/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated:  10/23/2015
The Mayo Clinic
mi
from
Rochester, MN
Rituximab in Progressive IgA Nephropathy
A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
Status: Enrolling
Updated: 10/23/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Status: Enrolling
Updated:  10/23/2015
The Mayo Clinic
mi
from
Rochester, MN
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Status: Enrolling
Updated: 10/23/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation
Status: Enrolling
Updated:  11/2/2015
University of Arizona
mi
from
Tucson, AZ
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation
Status: Enrolling
Updated: 11/2/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation
Status: Enrolling
Updated:  11/2/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation
Status: Enrolling
Updated: 11/2/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation
Status: Enrolling
Updated:  11/2/2015
Wake Forest University
mi
from
Winston-Salem, NC
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation
Status: Enrolling
Updated: 11/2/2015
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation
Status: Enrolling
Updated:  11/2/2015
The Methodist Hospital Research Institute
mi
from
Houston, TX
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation
Status: Enrolling
Updated: 11/2/2015
The Methodist Hospital Research Institute
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated:  11/2/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated: 11/2/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated:  11/2/2015
University of Southern California
mi
from
Los Angeles, CA
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated: 11/2/2015
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated:  11/2/2015
Stanford University
mi
from
Stanford, CA
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated: 11/2/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated:  11/2/2015
Harbor - University of California Los Angeles Medical Center
mi
from
Torrance, CA
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated: 11/2/2015
Harbor - University of California Los Angeles Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated:  11/2/2015
Danbury Hospital
mi
from
Danbury, CT
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated: 11/2/2015
Danbury Hospital
mi
from
Danbury, CT
Click here to add this to my saved trials
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated:  11/2/2015
River City Clinical Research
mi
from
Jacksonville, FL
A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status: Enrolling
Updated: 11/2/2015
River City Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials